Products
Products
Suppliers
News
Search
All Categories
Products or Suppliers
Content Hub
Product Zone
Sponsorship & Membership
CPHI & PMEC China
Active Pharmaceutical Ingredients
Intermediates&Fine Chemicals
Bio Products
Natural Extracts
Finished Dosage
Pharmaceutical Excipients
Pharmaceutical Outsourcing, Customised Services, and Consulting
Medical Aesthetic Skincare
Food Ingredients
API Equipment
Preparation Equipment
Pharmaceutical Packaging Machinery
TCM Machinery
Pharmaceutical water equipment
Clean Technology
Refrigeration Equipment
Parts and Components
Informatization Products
Laboratory
Packaging Materials
Measuring Instrument
Environmental Protection Equipment
Logistics
Other Consumables
Dietary Supplements‌‌
Correctives
Colorant
Filtration separation
Intelligent Logistics
Cold chain Technical &Materials
Logistics Equipment &Materials
Storage Equipment &Materials
Logistic Services
Third-party logistics
Dangerous Goods Logistics
Level instrument
Pressure gauge
Thermometers
Flow meter
Gas analysis instrument
Liquid analysis instrument
Fermenter Equipment
Other Measuring Instrument
Other Logistics
Medical Aesthetic Consumables
Sera and Vaccines
Soft tube/Hard tube
Pharmaceutical Intermediates
Anti-tumor Preparations
Pharmaceutical Manufacturing Outsourcing
Chemical and Biochemical Reactors
Mixing Equipment
CIP System(Clean in place)
Herbal medicine Concentration Equipment
Purification Equipment
Low Temperature Refrigeration
Seals
Laboratory General Equipment
Functional Food Raw Materials
Inner packaging equipment
Polluted Water / Wastewater Treatment Equipment
Injection Raw Materials and Ingredients
IVD (In Vitro Diagnostics) Consumables
Suspending Agents / Thickening Agents
Concentrator Equipment
MES System
APIs for Anti-Infective Drugs
Biochemical APIs
Botanical products
Pharma Packaging Materials
Diluents (Fillers)
Intermediates for Agrochemicals
Reagent
Cardiovascular, Cerebrovascular, and Circulatory System Formulations
Pharmaceutical R&D Outsourcing
Drying Equipment
TCM Pulverizer
Water Purification Equipment
Purification Test Instrument
Air Conditioner
‌Sanitary Fittings
Analytical Instrument
Other Dipstick Consumables
Nutraceutical Ingredients
Granules Machinery
Outer packaging
Waste Gas Treatment Equipment
Active Ingredients
Binders
Solubilizers
Drug delivery systems
Sensors
APIs for Nervous System Drugs
Animal-derived products
Endocrine and Metabolic Preparations
Disintegrants
service
Crystalling Equipment
Pill Making Equipment
Other Water Treatment Equipment
Clean Clothes/Clean Cap/Clean Shoes
Cold Storage
Pumps
Food & Beverage Raw Materials
Life Science Instrument
Tablet equipment
Other pharmaceutical packaging equipment
Solid and Hazardous Waste Treatment Equipment
Innovative Materials
Controllers & Drivers
Speciality Intermediates
Microbial products
Humectants
APIs for Digestive System Drugs
APIs for Cardiovascular System Drugs
Antibacterial and Antiviral Formulations
Lubricants
Extraction Plant
Slice Machine
Clean Bench
‌Refrigeration Auxiliaries
Valves
Biologics
TCM Raw Materials
Food Additive
Reagents and Consumables
Capsule equipment
Pharmaceutical water equipment
Testing & Monitoring Instruments and Equipment
Other Medical Aesthetics & Skincare
Veterinary Pharmaceutical Intermediates
Automation Software
APIs for Respiratory System Drugs
Bio Technology Service
Antipyretic and Analgesic Preparations
Glidants / Anti-caking Agents
Heat Exchanger
Herbal medicine Drying Equipment
Air Shower Room
Compressor
Cylinders
Fine Chemicals
Crushing equipment
Ultrapure Water System
Other Automation & Informatization Products
OEM/ODM
Measuring Instruments
Energy-saving and Low-carbon Equipment
Other Intermediates
Antiparasitic Preparations
Coating Agents
Storage Tanks, Containers
Herbal medicine Extraction Equipment
Air Purification
Other Refrigeration Equipment
Drive Equipment‌
Liquid preparation equipment
Solution Preparation System
Other Environmental Protection Equipment
APIs for Hormones and Regulatory Drugs
Other Natural Products
Physical Testing
APIs for Antiparasitic Drugs
Anti-Allergic Formulations
Plasticizer
Evaporating Equipment
TCM Cooking Equipments
Cleanroom
Reducers
Laboratory Engineering
Biopharmaceutical Equipment
Membrane Module‌
APIs for Antipyretic and Analgesic Drugs
Anti-Tuberculosis and Anti-Leprosy Formulations
Surfactant
Distillation Equipment
Drop Pill Equipment
Purifying Engineering
VFD (Variable Frequency Drive)
Other preparation equipment
Distilled water machine
Laboratory Solutions
Vitamin
Digestive System Preparations
Centrifuge
Screening Machine
Honey Pill Machine
Flooring Materials
Bearing
Emulsifiers
Ion-exchange equipment
Online Process Control
Respiratory System Preparations
Sterilizing Equipment
TCM Deposition Equipment
Spare Part‌
Other Cleaning System
Stainless Steel
Nervous System Preparations
Filter press equipment
Herbal medicine Fermentation Equipment
Plastic
‌Containment System
Special Active Ingredients
Ointment Bases
Homogenizer Equipment
Other TCM Machinery
Others Parts and Components
APIs for Veterinary Drugs and Feed Additives
Anaesthetic and Adjuvant Formulations
Air Filter
Suppository Bases
Other Active Pharmaceutical Ingredients
Blood System Formulations
Cleanroom Consumables‌
Glass lining equipment
Film-forming Agents
Urinary and Reproductive System Formulations
Other API Machinery and Equipment
Filter Paper
Release Modifiers
Immunomodulatory Formulations
Filter Paper Board
smotic Pressure Regulators / Tonicity Adjusting Agents
Water, Electrolyte, and Acid-Base Balance Regulating Formulations
Ph Control Agents
Nozzle, Tank Cleaning Machine
Vitamin, Mineral, and Amino Acid Formulations
Antioxidants / Antioxidant Synergists
Fluid Equipment
Enzyme and Other Biochemical Formulations
Antimicrobial Preservatives (Preservatives)
Tonic and Nutritional Formulations
Complexing Agents (Chelating Agents / Inclusion Compounds)
Hormonal Formulations
Dermatological Preparations
Other Preparations
Co-solvents
ENT Preparations
Penetration Enhancers (Transdermal)
Freeze-drying Protective Agents
Refrigerants / Cryogens
Capsule
Fragrances
Adsorbents
Pressure-sensitive Adhesives (PSA)
Stiffening Agents
Carriers for Dry Powder Inhalers (DPI Carriers)
Other Excipients
Pipes and Pipe Fittings
Vacuum Equipment
Air Compressor
Compressor
Other Fluid Equipment
Prefillable Syringes
Filters
Filter Presstem
Filtration System
Filter Bag
Filter Mesh
Filter Cloth
Filter Membrane
Other Filtration Equipment
Sanitary Pressure Vessel‌
Hyaluronic Acid
Collagen
Botulinum Toxin
Peptide
Other Injection Raw Materials and Ingredients
Ceramide
Ectoin
Niacinamide
Asiaticoside
Ergothioneine
Chitosan
Other Active Ingredients
Chiral Intermediates
Advanced Intermediates
Microfiltration
Ultrafiltration
Auxiliary Equipment
Separation equipment
Metered Dose Inhalers
Dry Powder Inhalers
Penicillin
Hormones
Central Nervous System Drugs
Reagents for Biopharmaceuticals
Drug Target Discovery and Validation
Plant Extracts
Animal Extracts
Synthesis/Screening
Process Development/Optimisation/Scale-Up Production
Drug Registration and Submission Services
Ointment Filling-sealing Machine、Vacuum Mixer
Eye Drug Machinery
Soft Gelatin Capsule Machinery
Tablet Press
Pneumatic Cracker
Granulator
Labelers, Label Printers
Bag Packaging Machine
Thermostatic / Heating / Drying Equipment
Chromatography
Particle Size / Particle / Powder Analysis Instruments
Tabletop
Glass bottles & Vials
Fermentation Products
Prophylactic Biological Products
Mixing Tank/Blender
Bioreactor
Intravenous Infusion Set Assembly Equipment(Pen Assembly Equipment)
PCR
Recombinant Collagen
Alkaloids
Veterinary API
Regulated Fine Chemicals
Peptides
Balances / Weighing Scales
Online Gas Chromatography
Cephalosporins
Anesthetics
Immunology Reagents
Drug Development Technologies
Pharmaceutical Chemistry
Formulation Design
Regulatory and Compliance Consulting
Syrup Machinery
Injection Medicine Machinery
Hard Capsule Filling Machine
Coating Machine
Medicine Material Grinding Machine
Lettering machine
Box Packaging Machine
Mass Spectrometry
Laboratory Bench
Aluminum Foil
Rheometers / Viscometers
‌Chemical Reagents
Cleaning & Disinfection Equipment
Granulator
Emulsifier
Biological Fermentation System
Injection Molding Equipment
Exosome
Phospholipids
Prostaglandins
Veterinary Biologics
Chemical Reagents
Therapeutic Biological Products
Biochemical Reagents
Antibodies
Natural Pigments
Animal Lipids
Enzyme Preparations
Flowmeters
Online Particle Size Analyzer
Tetracycline
Amino Acids and Derivatives
Process Optimization and Testing
Nucleic Acids and Derivatives
Pre-Clinical Research
Chemical/Biological API Manufacturing
Powder Filling Machine
Oral Liquid Machinery
Low Temperature Pulverizer
Strapping machine
Paper Film Packaging Machine
Thermal Analyzers
Spectrometers
Other Measurement and Metrology Instruments
Storage Cabinets
Plastic Bottles
Other Industrial Process Control and Online Analytical Instruments
Certification
Feed Additives
Diagnostic Biological Products
Pulverizer
Coating Machine
Capsule Filling Machine
Other Mixing Equipment
Cell Engineering Equipment
Pre-filled Syringe Production Equipment
Purification Equipment
Electrophoresis/Gel Imaging/UV Detection
Regenerative Materials
Other Fine Chemicals
Cell Biology Reagents
Biological Consumables
Feed Additives
Soft Mist Inhaler
Plant Polysaccharides
Animal Proteins
Microbial Polysaccharides
Aminoglycoside
Enzymes
Molecular Biology Reagents
Clinical Trials
Intermediate Synthesis and Production
Market and Business Strategy Consulting
Suppository Drug Machinery
Powder Injection Machinery
Pharmaceutical Milling Machinery
Printing Device
Blister Packaging Machine
Environmental Test Chambers
Moisture Analyzer
Air Discharge Equipment
Rubber Stopper
Tablet Press
Other Tablet Equipment
Capsule Production Line
Isolator
Synthesis/Reaction Equipment
Microbial Detection Instrument
Composite Biomaterials
Animal Breeding Auxiliary Products
Packaging Testing Equipment
Laboratory Glassware and General Consumables
Preclinical Research Services
Nebulizer
Essential Oils
Animal Polysaccharides
Bioactive Functional Ingredients
Macrolides
Microbial / Fermentation Reagents
Proteins
Other Technology Services
Biotechnology Services
Formulation Development and Manufacturing
Other Services
Medicine Film Drug Machinery
Infusion Medicine Machinery(中文站有输液剂机械的三级分类)
Pharmaceutical Machine Milling
Instruction Booklet Folding Machine
Fan
Chromatography Consumables and Accessories
Other Physical Properties Testing Instruments
Gasket
Sample Preparation / Digestion Equipment
X-ray Structure Analysis
Safety Cabinet
Counting Machine (Tablet)
Other Capsule Filling Equipment
Disposable Biotechnology Equipment
Vacuum Packaging Machine
Laboratory Low-temperature Storage
Other Innovative Materials
Other Veterinary
Conveying equipment
Natural Spices
Bile Acids and Active Ingredients
Sulfonamides
Other Specialized Reagents
Computational Chemistry and AI-Assisted Drug Design
Clinical Trial Drug Manufacturing
Aerosol Drug Machinery
Super Micro Mill
Bottle Conveyer
Bundling Packaging Machine
Mixing/Dispersion Equipment
Other Laboratory Complete & Ancillary Equipment
Trays
Other Laboratory Consumable
Other Preparation Machinery for Solid Medcine
‌Centrifugal Separation System
Automatic Packaging Machine
Other Analytical Instrument
Chip System/Accessories
Cytokines
Counting Machine
Cartridge Vial
Medicinal Herbs
Bee Products
Chloramphenicols
Testing
Other Pharmaceutical Manufacturing Outsourcing
Medicine Filling Machine
Disk Type Bottle Straightening Machine
Lidding Materials
Other Crushing Equipment
Ultrafiltration/Microfiltration System
Horizontal Pillow Packaging Machine
Cartoning Machine
Auto-injector
Transfection/Cell Fusion
Track & Trace
Gas Generators / Gas Handling Equipment
Blood Products
TCM Ingredients & Slices
Animal Medicinal Materials
Lincomycin
Microbial Products
Bottle Washer
Vial Sealing Machine
Liquid Handling Equipment
Hoses and Fittings
Other Biopharmaceutical Equipment
Vertical Packaging Machine
Casing Machine
Microplate Reader/Enzyme Labeling Instrument
Analysis and Validation
Serialization System
Pen Injector
Other Anti-Infective Drug
Other Pharmaceutical R&D Outsourcing
Conveyer For Medicine Material
Spray Pump
Other Injectable Equipment
Aluminum Foil Packaging Machine
Coding Machine
Cell Analysis
Automated Assembly
Other Laboratory General Equipment
Packaging Bag Valve
Freeze Dryer
Granule packaging machine
Other Drug Delivery Device Accessories
Biological Microscope/In Vivo Imaging
Other Antibiotics
Cap Screwing Machine
Nasal Drug Delivery Devices / Nasal Spray Pumps
Printing Services‌
Liquid Packaging Machine
Laboratory Automation
Screw Capping Machine
Lamp Inspection Machine
Ophthalmic Drug Delivery Devices / Eye Drop Delivery Systems
Labelling
Powder Packaging Machine
Synthesizer
Heat Shrink Packaging Machine
Metal Detector
Insulin Pens / Blood Glucose Management Devices
Security Taggants & Markings
Filter Cartridge‌
Tablet Packaging Machine
Animal Experiment Instrument
Injection & blow molding machines
Batching system
Self-Injection Systems / Safety Protection Devices
Incubator Equipment
Printed Drugs Packaging
Box filling & sealing machine
Palletizing equipment
CIP cleaning system
Topical / Gynecological / Intimate Drug Delivery Devices
Desiccants
Other Life Science Instrument
Bottle Filling Line
Contaners
Lifting Charging Machine
Others
Inhalant Packaging
BFS Bottlepack Machine
Weighting Equipment
Blister Packaging Machine
Pharmaceutical Paper
Other Pharmaceutical Outer Packaging Equipment
Packaging bag valve
Container Sealing Machine
Glass Tube
Multi-functional Bottle Packaging Machine
Medical Aesthetic Freeze-Dried Powder Vials
Sachets Cartoner Packing line
Primary Packaging
Other Pharmaceutical Inner Packaging Equipment
Aluminum Caps & Aluminum-Plastic Combination Caps
Sterile Bags / Breathing Bags / Sterilization Bags
Medical Device Packaging / Bioconsumables Packaging
Dispensing Bottles
Blister Packaging
Pharmaceutical Plastic Films / Composite Film Bags
Accessories
Ampuls
Other Packaging Materials
Home
Products
Anti-tumor Preparations
Palonosetron Hydrochloride Injection
Palonosetron Hydrochloride Injection

Palonosetron Hydrochloride Injection

Category:
Anti-tumor Preparations
Standard:
N;
Price Range:
Get Quote
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Send inquiry
Jiangsu Simcere Pharmaceutical Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd.
6
Years
Show Room
Favorites

Basic Info

Is Manufacturer
No
Samples Provided
NO
Packaging & Delivery
Packaging Specification
Box Carton
Minimum Order Quantity
10,000 Ampoules

Product Description

Palonosetron Hydrochloride Injection

 

Generic name: Palonosetron Hydrochloride Injection
Brand name: Lowvo
Composition:
The main ingredient of this product is Palonosetron hydrochloride.
Chemical name:  (3aS)-2-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-1H- benz[de]isoquinolin-1
-one monohydrochloride
Chemical structure:

 

Palonosetron Hydrochloride Injection
 

 

Molecular formula: C19H24N2O·HCl
Molecular weight: 332.87
Description: This product is colorless and clear liquid.
Indications:
1. Prevention of acute nausea and vomiting caused by severe emetogenic chemotherapy;
2. Prevention of nausea and vomiting caused by moderate emetogenic chemotherapy;
Strength: 5mL : 0.25mg (based on C19H24N2O)
Dosage and Administration:
The recommended dose is, about 30 minutes before chemotherapy, a single intravenous dose  Palonosetron
hydrochloride 0.25mg, injection time of 30 seconds or more.
Contraindications:
Contraindicated in patients with known hypersensitivity to the drug or any component of the drug.
Precautions:
Allergic reactions may occur to patients of other selective 5-HT3 receptor antagonist allergy.
Palonosetron did not lead to clinically significant QTc interval prolongation at the dose levels studied in clinical
trials abroad. In a complete QT / QTc study of double-blind, randomized, parallel, placebo-controlled and
positive controls (moxifloxacin) in 221 healthy adult male and female volunteers, the affect of Palonosetron on
QTc interval was evaluated. The results showed that no effects on QTc interval and other ECGs were
observed at doses of 0.25 mg, 0.75 mg, 2.25 mg and no clinically significant changes in heart rate,
atrioventricular conduction and cardiac repolarization were observed neither. However, based on information
of other 5-HT3 receptor antagonist, Palonosetron should be used with caution in patients with prolonged QT
intervals and with or expected to develop QT interval prolongation. These patients include those with
hypokalemia or hypomagnesemia, patients with electrolyte abnormalities caused by taking diuretics, patients
with congenital QT syndrome, patients taking antiarrhythmic or other medications that lead to prolonged QT
intervals, and patients who have given cumulative high-dose anthracycline treatment.
Palonosetron hydrochloride injection can not be mixed with other drugs, so before and after the use of Palono-
setron hydrochloride injection, both need to apply saline flush infusion line.
Clinical studies:
The following data are mainly from foreign research literature.
In three phase III clinical studies and one phase II clinical study, the efficacy of a single dose of Palonosetron
in the prevention of acute and delayed nausea and vomiting caused by moderate and highly emetogenic che-
motherapy was evaluated. In these double-blind clinical studies, complete remission for at least 120 hr after
chemotherapy (no episodes of vomiting and no medication) and other efficacy parameters were evaluated;
and the safety and efficacy of Palonosetron in repeat chemotherapy were evaluated.
Moderate emetogenic chemotherapy
In two phase III double-blind clinical trials, clinical study case number of 1132, 30 minutes prior to moderate
emetogenic chemotherapy, volunteers were given a single intravenous dose of Palonosetron and a single
intravenous dose of Ondansetron (Study 1) and Dolasetron (Study 2). Chemotherapeutic agents used include
carboplatin ≤50 mg/m2, cyclophosphamide <1500 mg/m2, doxorubicin>25 mg/m2, epirubicin, irinotecan, me-
thotrexate>250 mg/m2. Patients in Study 1 was not given prophylactic corticosteroids. Only 4-6% of patients
in Study 2 were given corticosteroids. 77% of the patients in this study were female, 65% were caucasian and
54% were initial chemotherapy. The average age was 55 years old.
Highly emetogenic chemotherapy
In a phase II, double-blind, clinical trial, 161 patients who received initial chemotherapy received highly emet-
ogenic chemotherapy (cisplatin ≥70 mg/m2 or cyclophosphamide>1100 mg/m2) and the efficacy of a single
dose of Palonosetron 0.3-90 µg/kg (equivalent to a fixed dose of <0.1 mg-6 mg) was evaluated. Corticostero
ids were not given prophylactically. Experimental data analysis showed that 0.25 mg Palonosetron is the
lowest effective dose to inhibit acute nausea and vomiting induced by severe emetogenic chemotherapy.
In a phase III, double-blind, clinical trial involving 667 patients, a single intravenous injection of Palonosetron
 or Ondansetron were performed 30 minutes prior to severe emetogenic chemotherapy (cisplatin ≥60 mg/m2,
 or cyclophosphamide>1500 mg/m2, dacarbazine) , the therapeutic efficacy of Palonosetron and Ondansetron
were compared (Study 3). 67% of patients received corticosteroids prior to chemotherapy, 51% were female,
60% were caucasian, and 59% were initial chemotherapy. The average age was 52 years old.
Clinical results
Phase III clinical efficacy of Palonosetron in the prevention of acute (0-24 hr) vomiting evaluation results in
Table 1, the prevention of delayed (24-120 hr) vomiting evaluation results in Table 2, the overall (0-120 hr)
prevention of vomiting evaluation results are shown in Table 3.
Palonosetron Hydrochloride Injection
a  Number of treated cases
b  Bilateral Fisher's exact test. Significance level α = 0.025
c  Non-inferiority hypothesis tests were performed on these studies. A lower limit of -15% meets the n
on-inferiority assumption between Palonosetron and the control drug.

Studies have shown that Palonosetron is effective in preventing acute nausea and vomiting in patients who
have had initial or repeated chemotherapy with moderate or severe emetogenic. In Study 3, prophylactic
corticosteroids can enhance the efficacy. There is insufficient data to show that Palonosetron have clinical
advantages to other 5-HT3 receptor antagonists in prevention of nausea and vomiting during the acute phase.

Palonosetron Hydrochloride Injection

a  Number of treated cases
b  Bilateral Fisher's exact test. Significance level α = 0.025
c  Non-inferiority hypothesis tests were performed on these studies. A lower limit of -15% meets the
non-inferiority assumption between Palonosetron and the control drug.
    
Studies have shown that Palonosetron is effective in preventing delayed nausea and vomiting associated
with initial and repeated moderate emetogenic chemotherapy.

Palonosetron Hydrochloride Injection

a  Number of treated cases
b  Bilateral Fisher's exact test. Significance level α = 0.025
c  Non-inferiority hypothesis tests were performed on these studies. A lower limit of -15% meets the non-
inferiority assumption between Palonosetron and the control drug.

 Studies have shown that Palonosetron is effective in preventing nausea and vomiting at 120 hr (5 days) after
initial and repeated moderate emetogenic chemotherapy.
Pharmacology and toxicology:
Pharmacology
Palonosetron is a strong affinity 5-HT3 receptor selective antagonist with no affinity or lower affinity for other
receptors. The 5-HT3 receptor is located in the vagal nerve endings in and around the emetic induction zone
in the last region of the medulla oblongata. Chemotherapeutic drugs release 5-HT by stimulating small
intestine chromaffin cells. 5-HT reactivates vagal afferent 5-HT3 receptors and produces vomiting reflexes.
Toxicology
Carcinogenicity
In a continuous 104-week carcinogenicity study of CD-1 mice, animals were orally administered Palonosetron
at doses of 10, 30, and 60 mg/kg/day. The results showed that Palonosetron was non-carcinogenic. System
exposure (plasma AUC) of Palonosetron resulting from the highest test dose was 150-289 times the human
recommended intravenous dose of 0.25 mg after exposure to Palonosetron (AUC=29.8 ng.h/mL). In a 104
-week carcinogenicity study of SD rats, male and female rats were orally administered Palonosetron at doses
of 15, 30, 60 mg/kg /d and 15, 45, 90 mg/kg/day, respectively. System exposure (plasma AUC) of
Palonosetron resulting from the highest test dose was 137-308 times that of the human recommended i
ntravenous dose. And Palonosetron results in increased incidence of benign adrenal pheochromocytoma and
benign and malignant mixtures pheochromocytoma , pancreatic islet cell adenoma, mixed adenoma and s
arcoma and pituitary tumors in male rats. And it will lead to the increased incidence of hepatocellular
adenoma and sarcoma, thyroid C-cell adenomas, mixed adenoma and sarcoma increases in female rats.
Mutagenicity
Bacterial Ames test, Chinese hamster ovary cell mutagenicity test, in vitro hepatocyte disordered DNA
synthesis (UDS) test or mouse micronucleus test showed that Palonosetron has no mutagenicity. However,
Palonosetron has a distortion effect on the chromosome of Chinese hamster ovary cells.
Reproductive toxicity
Oral administration of rat dose of 60 mg/kg (by body surface area, about 1894 times of the recommended
intravenous injection for human), did not affect fertility of male and female rats.
Pharmacokinetics:
The following data are from foreign clinical research literature.
After administration of Palonosetron to healthy volunteers and cancer patients intravenously, as the drug
slowly eliminate in the body, plasma concentration begins to decline. Mean maximum plasma concentration
(Cmax) and area under the concentration-time curve (AUC0→∞) are generally dose-proportional over the
dose range of 0.3-90 µg/kg in healthy subjects and in cancer patients. Six cancer patients were given a single
dose of Palonosetron of 3 μg/kg (or 0.21 mg/70 kg), with a maximum plasma concentration of 5.6±5.5 ng/mL
and an average AUC of 35.8±20.9 ng.hr/mL.
Following intravenous administration of Palonosetron 0.25 mg once every other day for 3 doses in 11
testicular cancer patients, the mean (± SD) increase in plasma concentration from Day 1-Day 5 was 42±34%.
After intravenous administration of Palonosetron 0.25 mg once daily for 3 days in 12 healthy subjects, the
mean (± SD) increase in plasma Palonosetron concentration from Day 1 to Day 3 was 110±45 %.
Distribution
The distribution volume of Palonosetron is 8.3±2.5L/kg, and the plasma protein binding rate is about 62%.
Biotransformation
Palonosetron is eliminated by dual route, approximately 50 % metabolised to form two primary metabolites,
which have less than 1 % of the 5HT3 receptor antagonist activity of palonosetron. In vitro metabolism studies
have shown that CYP2D6 and to a lesser extent, CYP3A and CYP1A2 isoenzymes are involved in the
metabolism of palonosetron. However, clinical pharmacokinetic parameters are not significantly different
between poor and extensive metabolisers of CYP2D6 substrates.
Elimination
A single dose of 10 μg/kg 14C Palonosetron was intravenously administered. After 144 hr, the radioactive
marker present in the urine accounted for about 80% of the administered dose, with Palonosetron about 40%
. The whole body clearance rate of healthy volunteers was 160±35 mL/h/ kg, the renal clearance rate was
66.5±18.2 mL/h/kg and the average terminal elimination half-life was 40 hours.
Elderly people
Population pharmacokinetic analysis and clinical safety and efficacy data show no difference between elderly
patients ≥65 years and young patients (18-64 years). Therefore, elderly patients do not need to adjust the dose.
Different races
Pharmacokinetic studies were performed on 24 Japanese healthy volunteers. Palonosetron administered
intravenously at a dose ranging from 3-90 μg/kg had 25% more systemic clearance than Caucasians, but did
not require dose adjustment. The melanoderm's pharmacokinetics of Palonosetron is not sufficient.
Renal impairment
Light to moderate renal impairment did not significantly affect pharmacokinetic parameters of Palonosetron,
and systemic exposure in patients with severe renal impairment increased by approximately 28% compared
to healthy volunteers. Therefore, patients with varying degrees of renal impairment do not need to adjust the
dose.
Hepatic impairment
Compared with healthy volunteers, hepatic impairment had no significant effect on the rate of systemic
clearance of Palonosetron, so no dose adjustments were needed for patients with varying degrees of hepatic
impairment.
Storage:Protect from light, and seal up.
Packs:Package material: ampoule bottle; Package size: 1 bottle/box, 2 bottle/box, 5 bottle/box.
Shelf-life:24 months